Fulcrum Therapeutics Inc. (FULC) Announces Interim Analysis Data from its ReDUX4 Trial in FSHD

Go back to Fulcrum Therapeutics Inc. (FULC) Announces Interim Analysis Data from its ReDUX4 Trial in FSHD
(NASDAQ: FULC) Delayed: 3.85 +0.08 (2.12%)
Previous Close $3.77    52 Week High
Open $3.69    52 Week Low
Day High $3.89    P/E N/A 
Day Low $3.69    EPS
Volume 2,813,605